Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies
Pathogens · 03.01.2024 · 13 (1) · 46
DOI: 10.3390/pathogens13010046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 03.01.2024. Verfasst von Ivana Lazarevic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Protein Isoforms, Hepatitis B virus, Antiviral Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Ministry of Science, Technological Development and Innovation, Republic of Serbia.
Abstract (Originalsprache)
The hepatitis B surface antigen (HBsAg) is a multifunctional glycoprotein composed of large (LHB), middle (MHB), and small (SHB) subunits. HBsAg isoforms have numerous biological functions during HBV infection—from initial and specific viral attachment to the hepatocytes to initiating chronic infection with their immunomodulatory properties. The genetic variability of HBsAg isoforms may play a role in several HBV-related liver phases and clinical manifestations, from occult hepatitis and viral reactivation upon immunosuppression to fulminant hepatitis and hepatocellular carcinoma (HCC). Their immunogenic properties make them a major target for developing HBV vaccines, and in recent years they have been recognised as valuable targets for new therapeutic approaches. Initial research has already shown promising results in utilising HBsAg isoforms instead of quantitative HBsAg for correctly evaluating chronic infection phases and predicting functional cures. The ratio between surface components was shown to indicate specific outcomes of HBV and HDV infections. Thus, besides traditional HBsAg detection and quantitation, HBsAg isoform quantitation can become a useful non-invasive biomarker for assessing chronically infected patients. This review summarises the current knowledge of HBsAg isoforms, their potential usefulness and aspects deserving further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Ivana Lazarevic, Ana Banko, Danijela Miljanovic
Förderung
- Wellcome Trust
- Ministry of Science, Technological Development and Innovation, Republic of Serbia
Zitieren
APA
Lazarevic, I., Banko, A., Miljanovic, D., & Cupic, M. (2024). Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies. Pathogens, 13(1), 46. https://doi.org/10.3390/pathogens13010046
Vancouver
Lazarevic I, Banko A, Miljanovic D, Cupic M. Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies. Pathogens. 2024;13(1):46. doi:10.3390/pathogens13010046
BibTeX
@article{Lazarevic2024,
author = {Lazarevic, Ivana and Banko, Ana and Miljanovic, Danijela and Cupic, Maja},
title = {Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {1},
pages = {46},
doi = {10.3390/pathogens13010046}
}
EUVIMED